S J Harbison, M W Whitehouse. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAgedAnimalsAnti-Asthmatic Agents/administration & dosageAnti-Asthmatic Agents/therapeutic useAsthma/drug therapyBivalviaFemaleHumansLipids/administration & dosageLipids/therapeutic useLipoxygenase Inhibitors/administration & dosageLipoxygenase Inhibitors/therapeutic useOsteoarthritis/drug therapy
Substances: See more » Anti-Asthmatic AgentsLipidsLipoxygenase Inhibitorslyprinol
Year: 2000 PMID: 11194748 DOI: 10.5694/j.1326-5377.2000.tb139341.x
Source DB: PubMed Journal: Med J Aust ISSN: 0025-729X Impact factor: 7.738